Enter assignee name

Trademarks = 3

Forward Citations = 8

Loading Chart...

4 inventors (with patents filed for the assignee):

John F Warlick (13 out of 37 patents)

John Patrick Finney (6 out of 6 patents)

Janey Lynn Watts (1 out of 1 patent)

4. Irwin Goldstein (1 out of 2 patents)

13 patents: Sort by Forward Citations

1. 12402898 - Acoustic shock wave or pressure pulse treatment for proptosis or exophthalmos (2025-09-02),

2. 12303721 - Acoustic shock wave treatment and devices for appendages (2025-05-20),

3. 11903894 - Acoustic shock wave therapeutic methods to prevent or treat opioid addiction (2024-02-20),

4. 11844739 - Handheld acoustic shock wave or pressure pulse application device and methods of use (2023-12-19),

5. 11826301 - Acoustic shock wave therapeutic methods (2023-11-28),

6. 11771621 - Acoustic shock wave therapeutic methods to prevent or treat opioid addiction (2023-10-03),

7. 11771620 - Acoustic shock wave therapeutic methods to prevent or treat opioid addiction (2023-10-03),

8. 11458069 - Acoustic shock wave therapeutic methods to treat medical conditions using reflexology zones (2022-10-04),

9. 11389373 - Acoustic shock wave therapeutic methods to prevent or treat opioid addiction (2022-07-19),

10. 11389372 - Acoustic shock wave therapeutic methods (2022-07-19),

11. 11389371 - Acoustic shock wave therapeutic methods (2022-07-19),

12. 11389370 - Treatments for blood sugar levels and muscle tissue optimization using extracorporeal acoustic shock waves (2022-07-19),

13. 11311454 - Handheld acoustic shock wave or pressure pulse application device and methods of use (2022-04-26),

Softwave Tissue Regeneration Technologies, LLC is a leading biotechnology company focused on developing innovative therapies for tissue regeneration. Our cutting-edge technologies aim to revolutionize the treatment of various medical conditions by promoting natural healing processes. With a team of experienced scientists and researchers, we are committed to advancing the field of regenerative medicine and improving patient outcomes.

Profile summary based on public USPTO records.